Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/0714 : 04GlobeNewswire Inc.Coloplast strengthens ostomy care portfolio with three significant product launchesTG:CBHDColoplast AS
2024/05/0714 : 00GlobeNewswire Inc.Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24TG:CBHDColoplast AS
2024/05/0714 : 00GlobeNewswire Inc.TGS Launches Multi-Client Wind and Metocean Measurement Campaign Offshore GermanyTG:TGCTGS ASA
2024/05/0714 : 00GlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesTG:AYJValneva SE
2024/05/0714 : 00GlobeNewswire Inc.BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionNYSE:GSKGSK plc
2024/05/0714 : 00GlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesEU:VLAValneva SE
2024/05/0714 : 00GlobeNewswire Inc.Solvay first quarter 2024 resultsTG:SOLSolvay SA
2024/05/0714 : 00Business WireInnate Pharma organise une conférence téléphonique pour présenter ses résultats au premier trimestre 2024EU:IPHInnate Pharma
2024/05/0714 : 00Business WireInnate Pharma Announces Conference Call and Webcast for Q1 2024 Business UpdateEU:IPHInnate Pharma
2024/05/0714 : 00Business WireGalderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
2024/05/0714 : 00Business WireInnate Pharma organise une conférence téléphonique pour présenter ses résultats au premier trimestre 2024NASDAQ:IPHAInnate Pharma SA
2024/05/0714 : 00GlobeNewswire Inc.Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activitésEU:VLAValneva SE
2024/05/0714 : 00Business WireARKEMA : RÉSULTATS DU 1ER TRIMESTRE 2024TSX:AKEAlikem Limited
2024/05/0714 : 00GlobeNewswire Inc.Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activitésTG:AYJValneva SE
2024/05/0714 : 00GlobeNewswire Inc.Résultats du premier trimestre 2024EU:SOLBSolvay SA
2024/05/0714 : 00Business WireInnate Pharma Announces Conference Call and Webcast for Q1 2024 Business UpdateNASDAQ:IPHAInnate Pharma SA
2024/05/0714 : 00GlobeNewswire Inc.argenx to Present at BofA Securities 2024 Health Care ConferenceEU:ARGXArgen X SE
2024/05/0714 : 00GlobeNewswire Inc.Start of Day Message
2024/05/0714 : 00GlobeNewswire Inc.Fingerprint Cards AB (publ) publishes interim report for January – March 2024TG:FPQ1Fingerprint Cards AB
2024/05/0714 : 00Business WireArkema: First-Quarter 2024 ResultsTSX:AKEAlikem Limited
2024/05/0714 : 00GlobeNewswire Inc.Résultats du premier trimestre 2024TG:SOLSolvay SA
2024/05/0714 : 00GlobeNewswire Inc.BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionLSE:GSKGsk Plc
2024/05/0714 : 00GlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesLSE:0OB3Valneva Se
2024/05/0714 : 00GlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesVLAP
2024/05/0714 : 00GlobeNewswire Inc.argenx to Present at BofA Securities 2024 Health Care ConferenceNASDAQ:ARGXargenx SE
2024/05/0714 : 00GlobeNewswire Inc.Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activitésLSE:0OB3Valneva Se
2024/05/0714 : 00GlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesEU:VLAValneva SE
2024/05/0714 : 00GlobeNewswire Inc.Solvay first quarter 2024 resultsEU:SOLBSolvay SA
2024/05/0714 : 00PR Newswire (Canada)Rock Tech Lithium provides update on German subsidy applicationTSXV:RCKRock Tech Lithium Inc
2024/05/0714 : 00PR Newswire (US)Lonestar Data Holdings Unveils Revolutionary "Freedom Payload" Designed by Bjarke Ingels Group for Second Lunar Data Center Mission